Improving Pneumococcal Vaccination Rates in High Risk Patients Across Multiple Specialty Divisions

Authors

Rachel Moran, Children's Mercy HospitalsFollow
Julia G. Harris, Children's Mercy HospitalFollow
Claire Olsen, Children's Mercy Hospital
Rana El Feghaly, Children's MercyFollow
Liset Olarte, Children's Mercy HospitalFollow
Douglas Blowey, Children's Mercy HospitalFollow
Luke A. Harris, Children's Mercy HospitalFollow

Publication Date

10-2019

Files

Abstract

Pediatric patients with deficient immune systems or certain chronic medical conditions have an increased risk of acquiring invasive pneumococcal disease.

The 23-valent pneumococcal (PPSV23) vaccine provides protection against 23 pneumococcal serotypes and is recommended for patients aged 2 years or older who are high-risk for invasive pneumococcal disease.

Unfortunately, many high-risk patients are not properly vaccinated due to lack of provider knowledge or understanding of accountability between primary care and specialty providers.

The goal of this project was to improve PPSV23 vaccination rates by 10-20% across multiple Children's Mercy Kansas City specialty divisions.

MeSH Keywords

Pneumococcal Vaccines; Vaccination Coverage; Outpatient Clinics, Hospital; Child, Preschool; Child; Adolescent; Quality Improvement

Keywords

23-valent pneumococcal vaccine; PPSV23; specialty clinics

Disciplines

Bacterial Infections and Mycoses | Infectious Disease | Pediatrics | Pulmonology | Rheumatology

Recommended Citation

Moran, Rachel; Harris, Julia G.; Olsen, Claire; El Feghaly, Rana; Olarte, Liset; Blowey, Douglas; and Harris, Luke A., "Improving Pneumococcal Vaccination Rates in High Risk Patients Across Multiple Specialty Divisions" (2019). Posters. 141.
https://scholarlyexchange.childrensmercy.org/posters/141